Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SIMON PROPERTY GROUP INC.SPG · Entity 2946 | Director | September 30, 2026 | October 01, 2026 |
| SYSCO CORPSYY · Entity 2003 | Director | September 30, 2026 | October 03, 2026 |
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Director | May 08, 2020 | May 12, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SIMON PROPERTY GROUP INC.
Report date September 30, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,269 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Purchase · Acquired 367 · Balance 46,269 F1: Represents shares of common stock acquired through the reinvestment of dividends received on restricted stock awarded to the Reporting Person as non-cash compensation under the Simon Property Group, L.P. 2019 Stock Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock acquired through the reinvestment of dividends received on restricted stock awarded to the Reporting Person as non-cash compensation under the Simon Property Group, L.P. 2019 Stock Incentive Plan.
SYSCO CORP
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 105,171.492 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 334 · Balance 105,171.492 F1: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 175 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 175 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan.
ZIMMER BIOMET HOLDINGS, INC.
Report date May 08, 2020 · Filed May 12, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $120.68 | Direct | 22,348.068 |
Reported balance
After 2020-05-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-05-08 · Grant · Acquired 500 · Balance 22,348.068 F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F3: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4: Includes 154.831 phantom stock units accrued between July 31, 2019 and April 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,545.163 |
Reported balance
After 2020-05-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-05-08 · Grant · Acquired 1,077.229 · Balance 19,545.163 F2: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F5: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. |
Filing footnotes · ownership attribution and instrument terms
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of the Derivative Security is 1-for-1.
F3: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
F4: Includes 154.831 phantom stock units accrued between July 31, 2019 and April 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F5: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
F6: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2021 Filed Jan 4, 2022 01:59 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 224 | $77.94 | $17,458.56 |
DisclosureSEC source: 0000096021-22-000006 · wf-form4_164126153023369.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,519.89 F1 · shares: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 160 to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:13 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 2,469 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-21-000145 · wf-form4_163762276136820.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,295.89 F1 · shares: This grant shall vest on the first anniversary of the grant date. F2 · price: Represents restricted stock issued pursuant to the 2018 Sysco Corporation Omnibus Incentive Plan. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 21:18 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 215 | $80.93 | $17,399.95 |
DisclosureSEC source: 0000096021-21-000119 · wf-form4_163312308216474.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,398.358 F1 · shares: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 154 to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 15:42 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | PurchaseCommon Stock | 209 | $132.65 | $27,723.85 |
DisclosureSEC source: 0001179110-21-009110 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,521 F1 · kind: Represents shares of common stock acquired through the reinvestment of dividends received on restricted stock awarded to the Reporting Person as non-cash compensation under the Simon Property Group, L.P. 2019 Stock Incentive Plan. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 19:39 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | PurchaseCommon Stock | 207 | $123.87 | $25,641.09 |
DisclosureSEC source: 0001179110-21-007643 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,312 F1 · kind: Represents shares of common stock acquired through the reinvestment of dividends received on restricted stock awarded to the Reporting Person as non-cash compensation under the Simon Property Group, L.P. 2019 Stock Incentive Plan Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 21:18 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 231 | $75.68 | $17,482.08 |
DisclosureSEC source: 0000096021-21-000055 · wf-form4_162517428246036.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,733.915 F1 · shares: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 165 to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:37 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | GrantCommon Stock | 1,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005372 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,105 F1 · kind: Non-cash compensation - Award of restricted stock under the Simon Property Group, L.P. 2019 Stock Incentive Plan. The restricted stock vests one year after the award. F1 · price: Non-cash compensation - Award of restricted stock under the Simon Property Group, L.P. 2019 Stock Incentive Plan. The restricted stock vests one year after the award. Read SEC document |
| April 23, 2021 Filed Apr 26, 2021 20:17 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | PurchaseCommon Stock | 183 | $116.37 | $21,295.56 |
DisclosureSEC source: 0001179110-21-004607 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,334 F1 · kind: Represents shares of common stock acquired through the reinvestment of dividends received on restricted stock awarded to the Reporting Person as non-cash compensation under the Simon Property Group, L.P. 2019 Stock Incentive Plan. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 21:27 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 221 | $79.03 | $17,465.63 |
DisclosureSEC source: 0000096021-21-000030 · wf-form4_161731242198497.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,082.743 F1 · shares: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 158 to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| January 22, 2021 Filed Mar 22, 2021 21:28 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | PurchaseCommon Stock | 227 | $92.44 | $20,982.75 |
DisclosureSEC source: 0001179110-21-003675 · edgar.xml · nonDerivative · entry 3 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,151 F1 · kind: Represents shares of common stock acquired through the reinvestment of dividends received on restricted stock previously received by the Reporting Person as non-cash compensation under the Simon Property Group, L.P. 2019 Stock Incentive Plan. Read SEC document |
| December 31, 2020 Filed Dec 31, 2020 22:13 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 238 | $73.29 | $17,443.02 |
DisclosureSEC source: 0000096021-20-000159 · wf-form4_160945278427981.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,441.628 F1 · shares: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 170 to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 22:15 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 2,570 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-20-000131 · wf-form4_160591052408840.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,203.628 F1 · shares: This grant shall vest on the first anniversary of the grant date. F2 · price: Represents restricted stock issued pursuant to the 2018 Sysco Corporation Omnibus Incentive Plan. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| October 23, 2020 Filed Mar 22, 2021 21:28 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | PurchaseCommon Stock | 306 | $67.58 | $20,678.10 |
DisclosureSEC source: 0001179110-21-003675 · edgar.xml · nonDerivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,924 F1 · kind: Represents shares of common stock acquired through the reinvestment of dividends received on restricted stock previously received by the Reporting Person as non-cash compensation under the Simon Property Group, L.P. 2019 Stock Incentive Plan. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:29 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 285 | $61.17 | $17,433.45 |
DisclosureSEC source: 0000096021-20-000108 · wf-form4_160158773559729.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,148.32 F1 · shares: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 204 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| July 24, 2020 Filed Mar 22, 2021 21:28 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | PurchaseCommon Stock | 328 | $61.66 | $20,224.48 |
DisclosureSEC source: 0001179110-21-003675 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,618 F1 · kind: Represents shares of common stock acquired through the reinvestment of dividends received on restricted stock previously received by the Reporting Person as non-cash compensation under the Simon Property Group, L.P. 2019 Stock Incentive Plan. Read SEC document |
| June 30, 2020 Filed Jun 30, 2020 21:12 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 320 | $54.42 | $17,414.40 |
DisclosureSEC source: 0000096021-20-000052 · wf-form4_159355153368635.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,300.92 F1 · shares: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 229 to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| May 12, 2020 Filed May 14, 2020 14:30 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | GrantCommon Stock | 3,629 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-005943 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,290 F1 · kind: Non-cash compensation - Award of restricted stock under the Simon Property Group, L.P. 2019 Stock Incentive Plan. The restricted stock vests one year after the award. F1 · price: Non-cash compensation - Award of restricted stock under the Simon Property Group, L.P. 2019 Stock Incentive Plan. The restricted stock vests one year after the award. Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:33 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,077.229 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000102 · edgar.xml · derivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,545.163 Underlying: Common Stock · 1,077.229 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:33 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.68 | $0.00 |
DisclosureSEC source: 0000911916-20-000102 · edgar.xml · derivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,348.068 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 154.831 phantom stock units accrued between July 31, 2019 and April 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2020 Filed Mar 31, 2020 21:10 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 376 | $46.35 | $17,427.60 |
DisclosureSEC source: 0000096021-20-000032 · wf-form4_158568898947112.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,219.89 F1 · shares: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 269 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 22:17 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | PurchaseCommon Stock | 10,000 | $58.98 | $589,788.00 |
DisclosureSEC source: 0001179110-20-003982 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,661 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $58.67 to $59.48, inclusive. The reporting person undertakes to provide to Simon Property Group, Inc., any security holder of Simon Property Group, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: Includes 649 common shares acquired through the reinvestment of dividends received on common shares Q2 through Q4 2019 and Q1 of 2020 under the Company's Stock Incentive Plan. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 21:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative | 2,203 | $0.00 Strike: $61.04 | $0.00 |
DisclosureSEC source: 0000911916-20-000067 · edgar.xml · derivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,203 shares Expires 2020-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 21:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,203 | $61.04 | $134,471.12 |
DisclosureSEC source: 0000911916-20-000067 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 25 shares purchased under the dividend reinvestment plan for Zimmer Biomet Holdings, Inc.'s common stock between April 30, 2019 and February 4, 2020. F2 · balance_after: Includes 40 shares held directly through a trust, which shares were previously reported as being held indirectly by the reporting person. Read SEC document |
| December 31, 2019 Filed Dec 31, 2019 21:45 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 203 | $85.80 | $17,417.40 |
DisclosureSEC source: 0000096021-19-000173 · wf-form4_157782870306316.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,489.4 F1 · shares: Represents shares to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Plan, including 145 to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| November 15, 2019 Filed Nov 15, 2019 22:05 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-19-000136 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,286.4 F1 · shares: This grant shall vest on the first anniversary of the grant date. F2 · price: Represents restricted stock issued pursuant to the 2018 Sysco Corporation Omnibus Incentive Plan. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| September 30, 2019 Filed Sep 30, 2019 21:21 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 189 | $78.87 | $14,906.43 |
DisclosureSEC source: 0000096021-19-000109 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,701.83 F1 · shares: Represents shares elected to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Incentive Plan, including 158 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| June 28, 2019 Filed Jun 28, 2019 20:36 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 212 | $70.44 | $14,933.28 |
DisclosureSEC source: 0000096021-19-000049 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,172.06 F1 · shares: Represents shares elected to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Incentive Plan, including 177 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000112 · edgar.xml · derivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,467.934 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000112 · edgar.xml · derivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,693.237 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 172.336 phantom stock units accrued between July 31, 2018 and April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 08, 2019 Filed May 10, 2019 19:25 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | GrantCommon Stock | 1,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-005869 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,012 F1 · kind: Non-cash compensation - Award of restricted stock under the Simon Property Group, L.P. 2019 Stock Incentive Plan. The restricted stock vests one year after the award. F1 · price: Non-cash compensation - Award of restricted stock under the Simon Property Group, L.P. 2019 Stock Incentive Plan. The restricted stock vests one year after the award. F2 · balance_after: Includes 423 common shares acquired through the reinvestment of dividends received on common shares Q2 through Q4 2018 and Q1 of 2019 under the Company's Stock Incentive Plan. Read SEC document |
| March 29, 2019 Filed Mar 29, 2019 21:03 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 225 | $66.26 | $14,908.50 |
DisclosureSEC source: 0000096021-19-000030 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,598 F1 · shares: Represents shares elected to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Incentive Plan, including 188 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| February 08, 2019 Filed Feb 11, 2019 21:32 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative | 3,092 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000032 · edgar.xml · derivative · entry 4 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,092 shares Expires 2019-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 11, 2019 21:32 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | PurchaseCommon Stock | 2,000 | $120.09 | $240,182.00 |
DisclosureSEC source: 0000911916-19-000032 · edgar.xml · nonDerivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,593 F2 · price: Represents the purchase of 2,000 shares in multiple transactions ranging in price from $119.99 to $120.19 per share, resulting in a weighted average purchase price of $120.091. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range. Read SEC document |
| February 08, 2019 Filed Feb 11, 2019 21:32 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 3,092 | $43.73 | $135,213.16 |
DisclosureSEC source: 0000911916-19-000032 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 33 shares purchased under the dividend reinvestment plan for Zimmer Biomet Holdings, Inc.'s common stock between January 29, 2018 and January 31, 2019. Read SEC document |
| December 28, 2018 Filed Dec 28, 2018 21:40 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 100 | $62.05 | $6,205.00 |
DisclosureSEC source: 0000096021-18-000222 · edgar.xml · nonDerivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,982.42 F2 · shares: Represents company match equal to 50% of the 201 shares described in Footnote 1. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| December 28, 2018 Filed Dec 28, 2018 21:40 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 241 | $62.05 | $14,954.05 |
DisclosureSEC source: 0000096021-18-000222 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,882.42 F1 · shares: Represents shares elected to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2018 Omnibus Incentive Plan, including 201 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| November 16, 2018 Filed Nov 19, 2018 22:07 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 2,794 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-18-000184 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,641.42 F1 · shares: This grant shall vest on the first anniversary of the grant date. F2 · price: Represents restricted stock issued pursuant to the 2018 Sysco Corporation Omnibus Incentive Plan. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| September 28, 2018 Filed Sep 28, 2018 20:44 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 85 | $72.83 | $6,190.55 |
DisclosureSEC source: 0000096021-18-000154 · edgar.xml · nonDerivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,559.71 F2 · shares: Represents company match equal to 50% of the 171 shares described in Footnote 1. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| September 28, 2018 Filed Sep 28, 2018 20:44 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 205 | $72.83 | $14,930.15 |
DisclosureSEC source: 0000096021-18-000154 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,474.71 F1 · shares: Represents shares elected to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2013 Long-Term Incentive Plan, including 171 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| June 29, 2018 Filed Jun 29, 2018 20:47 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 91 | $68.35 | $6,219.85 |
DisclosureSEC source: 0000096021-18-000097 · edgar.xml · nonDerivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,972.56 F2 · shares: Represents company match equal to 50% of the 182 shares described in Footnote 1. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| June 29, 2018 Filed Jun 29, 2018 20:47 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 218 | $68.35 | $14,900.30 |
DisclosureSEC source: 0000096021-18-000097 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,881.56 F1 · shares: Represents shares elected to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2013 Long-Term Incentive Plan, including 182 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:14 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,143.159 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000123 · edgar.xml · derivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,389.812 Underlying: Common Stock · 1,143.159 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:14 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000123 · edgar.xml · derivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,020.901 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 159.808 phantom stock units accrued between July 28, 2017 and April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 08, 2018 Filed May 10, 2018 18:58 UTC | SIMON PROPERTY GROUP INC. SPG · Entity 2946 | GrantCommon Stock | 1,386 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-006523 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,400 F1 · kind: Non-cash compensation - Award of restricted stock under the Simon Property Group, L.P. 1998 Stock Incentive Plan (as amended and restated April 4, 2014). The restricted stock vests one year after the award. F1 · price: Non-cash compensation - Award of restricted stock under the Simon Property Group, L.P. 1998 Stock Incentive Plan (as amended and restated April 4, 2014). The restricted stock vests one year after the award. F2 · balance_after: Includes 360 common shares acquired through the reinvestment of dividends received on common shares Q2 through Q4 2017 and Q1 of 2018 under the Company's Stock Incentive Plan. Read SEC document |
| March 30, 2018 Filed Mar 30, 2018 20:05 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 104 | $59.96 | $6,235.84 |
DisclosureSEC source: 0000096021-18-000057 · edgar.xml · nonDerivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,320.4 F2 · shares: Represents company match equal to 50% of the 208 shares described in Footnote 1. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| March 30, 2018 Filed Mar 30, 2018 20:05 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 249 | $59.96 | $14,930.04 |
DisclosureSEC source: 0000096021-18-000057 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,216.4 F1 · shares: Represents shares elected to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2013 Long-Term Incentive Plan, including 208 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 14:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative | 485 | $0.00 Strike: $72.59 | $0.00 |
DisclosureSEC source: 0000911916-18-000023 · edgar.xml · derivative · entry 3 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 485 shares Expires 2018-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 14:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 485 | $72.59 | $35,206.15 |
DisclosureSEC source: 0000911916-18-000023 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 59 shares purchased under the dividend reinvestment plan for Zimmer Biomet Holdings, Inc.'s common stock. Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 22:08 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 102 | $61.06 | $6,228.12 |
DisclosureSEC source: 0000096021-18-000006 · edgar.xml · nonDerivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,635.85 F2 · shares: Represents company match equal to 50% of the 204 shares described in Footnote 1. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 22:08 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 244 | $61.06 | $14,898.64 |
DisclosureSEC source: 0000096021-18-000006 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,533.85 F1 · shares: Represents shares elected to be received in lieu of a portion of non-employee director annual cash retainer fees pursuant to the Sysco Corporation 2013 Long-Term Incentive Plan, including 204 shares to be received in lieu of the base retainer. The receipt of these shares has been deferred pursuant to the 2009 Board of Directors Stock Deferral Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.